Clinical trial
OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab
NCT01243086 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab
- Lead sponsor
- McMaster University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- May 31, 2015
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.